公开(公告)号：UY27750A1

公开(公告)日：2003-11-28

申请号：UY27750

申请日：2003-04-04

Applicant: ABBOTT LAB

Inventor： DINGES JURGEN ,  HAVIV FORTUNA ,  VASUDEVAN ANIL ,  BRADLEY MICHAEL F ,  SAUER DARYL R ,  PARK DAVID C ,  HENKIN JACK ,  KOLACZKOWSKI LAWRENCE

IPC: A61P9/14 ,  A61K31/44 ,  C07D211/00 ,  C07D213/00 ,  C07D213/16

Abstract: Compuestos que tienen la fórmula son inhibidores de la angiogénesis. También se describen composiciones que contienen los compuestos, métodos para su preparación y métodos de tratamiento en los que se usan los compuestos.

公开(公告)号：CA2481240A1

公开(公告)日：2003-10-23

申请号：CA2481240

申请日：2003-04-03

Applicant: ABBOTT LAB

Inventor： HAVIV FORTUNA ,  KOLACZKOWSKI LAWRENCE ,  DINGES JUERGEN ,  SAUER DARYL R ,  PARK DAVID C ,  HENKIN JACK ,  BRADLEY MICHAEL F ,  VASUDEVAN ANIL

IPC: C07D241/24 ,  A61K31/4439 ,  A61K31/444 ,  A61K31/4545 ,  A61K31/455 ,  A61K31/4747 ,  A61K31/496 ,  A61K31/497 ,  A61K31/506 ,  A61K31/5355 ,  A61K31/541 ,  A61K31/551 ,  A61P1/00 ,  A61P3/10 ,  A61P5/00 ,  A61P9/00 ,  A61P15/00 ,  A61P17/00 ,  A61P27/02 ,  A61P35/00 ,  C07D213/81 ,  C07D213/82 ,  C07D239/28 ,  C07D401/04 ,  C07D401/06 ,  C07D401/12 ,  C07D401/14 ,  C07D403/06 ,  C07D405/04 ,  C07D405/12 ,  C07D405/14 ,  C07D409/04 ,  C07D409/14 ,  C07D491/10 ,  C07D491/113

Abstract: Compounds having the formula (I) are angiogenesis inhibitors. Also disclosed are compositions containing the compounds, methods of making the compounds, and methods of treatment using the compounds. A is selected from the group consisting of pyridine, pyridine N-oxide, pyridazine, pyrimidine. pyrazine, and triazine; R1 and R2, together with the nitrogen atom to which they are attached, form a five - to eight - membered ring containing an additional ze ro to two heteroatoms selected from the group consisting of nitrogen, oxygen, a nd sulfur; wherein the ring can be optionally substituted with one, two, or thr ee substituents independently selected from the group consisting of alkoxyalkyl , alkoxycarbonyl, alkyl, unsubstituted alkylcarbonyl, amino, aminocarbonyl, aryl, arylalkoxycarbonyl, wylalkyl, carboxy, formyl, haloalkyl, heterocycle, (heterocycle)alkyl, hydroxy, hydroxyalkoxyalkyl, hydroxyalkyl, and spiroheterocycle; R3 at each occurance is independently selected from the group consisting 'of alkenyl, alkoxy, alkoxyalkyl, alkoxycarbonyl, alkyl, unsubstituted alkylcarbonyl, alkylsulfanyl, amino, aminocarbonyl, aryl, arylalkyl, aryloxy, cyano, cyanoalkyl, cyanoalkyl, (cycloalkyl)alkyl, halo, haloalkyl, heterocycle, hydroxy, hydroxyalkyl, and nitro; X is selected from the group consisting of O, S, and CH2; and m is 0-4.

公开(公告)号：DK0882024T3

公开(公告)日：2002-05-21

申请号：DK96944941

申请日：1996-12-06

Applicant: ABBOTT LAB

Inventor： SHAM HING LEUNG ,  NORBECK DANIEL W ,  CHEN XIAOQI ,  BETEBENNER DAVID A ,  KEMPF DALE J ,  HERRIN THOMAS R ,  KUMAR GONDI N ,  CONDON STEPHEN L ,  COOPER ARTHUR J ,  DICKMAN DANIEL A ,  HANNICK STEVEN M ,  KOLACZKOWSKI LAWRENCE ,  OLIVER PATRICIA A ,  PLATA DANIEL J ,  STENGEL PETER J ,  STONER ERIC J ,  TIEN JIEH-HEH J ,  LIU JIH-HUA ,  PATEL KETAN M

IPC: C07D253/00 ,  A61K31/00 ,  A61K31/40 ,  A61K31/4015 ,  A61K31/41 ,  A61K31/415 ,  A61K31/4164 ,  A61K31/4166 ,  A61K31/4184 ,  A61K31/42 ,  A61K31/421 ,  A61K31/425 ,  A61K31/427 ,  A61K31/4427 ,  A61K31/443 ,  A61K31/4433 ,  A61K31/4439 ,  A61K31/47 ,  A61K31/495 ,  A61K31/496 ,  A61K31/4965 ,  A61K31/505 ,  A61K31/513 ,  A61K31/53 ,  A61K31/55 ,  A61K38/05 ,  A61K45/00 ,  A61P31/18 ,  A61P43/00 ,  C07C231/12 ,  C07C235/20 ,  C07C273/18 ,  C07C275/16 ,  C07D20060101 ,  C07D207/22 ,  C07D207/26 ,  C07D207/27 ,  C07D207/273 ,  C07D207/34 ,  C07D207/40 ,  C07D207/404 ,  C07D207/408 ,  C07D207/416 ,  C07D211/72 ,  C07D211/84 ,  C07D223/06 ,  C07D233/28 ,  C07D233/30 ,  C07D233/32 ,  C07D233/36 ,  C07D233/40 ,  C07D233/42 ,  C07D233/66 ,  C07D239/06 ,  C07D239/10 ,  C07D239/20 ,  C07D239/22 ,  C07D241/06 ,  C07D241/08 ,  C07D241/18 ,  C07D243/04 ,  C07D253/06 ,  C07D263/16 ,  C07D263/20 ,  C07D263/22 ,  C07D263/34 ,  C07D265/04 ,  C07D267/04 ,  C07D277/12 ,  C07D277/32 ,  C07D277/34 ,  C07D279/06 ,  C07D281/02 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/12 ,  C07D417/12

Abstract: A compound comprising a substituent of the formula (II) is disclosed as an HIV protease inhibitor. Intermediates for making such compounds and processes for making such intermediates are also disclosed.

公开(公告)号：AU725369B2

公开(公告)日：2000-10-12

申请号：AU1342297

申请日：1996-12-06

Applicant: ABBOTT LAB

Inventor： SHAM HING LEUNG ,  NORBECK DANIEL W ,  CHEN XIAOQI ,  BETEBENNER DAVID A ,  KEMPF DALE J ,  HERRIN THOMAS R ,  KUMAR GONDI N ,  CONDON STEPHEN L ,  COOPER ARTHUR J ,  DICKMAN DANIEL A ,  HANNICK STEVEN M ,  KOLACZKOWSKI LAWRENCE ,  OLIVER PATRICIA A ,  PLATA DANIEL J ,  STENGEL PETER J ,  STONER ERIC J ,  TIEN JIEH-HEH J ,  LIU JIH-HUA ,  PATEL KETAN M

IPC: C07D253/00 ,  A61K31/00 ,  A61K31/40 ,  A61K31/4015 ,  A61K31/41 ,  A61K31/415 ,  A61K31/4164 ,  A61K31/4166 ,  A61K31/4184 ,  A61K31/42 ,  A61K31/421 ,  A61K31/425 ,  A61K31/427 ,  A61K31/4427 ,  A61K31/443 ,  A61K31/4433 ,  A61K31/4439 ,  A61K31/47 ,  A61K31/495 ,  A61K31/496 ,  A61K31/4965 ,  A61K31/505 ,  A61K31/513 ,  A61K31/53 ,  A61K31/55 ,  A61K38/05 ,  A61K45/00 ,  A61P31/18 ,  A61P43/00 ,  C07C231/12 ,  C07C235/20 ,  C07C273/18 ,  C07C275/16 ,  C07D20060101 ,  C07D207/22 ,  C07D207/26 ,  C07D207/27 ,  C07D207/273 ,  C07D207/34 ,  C07D207/40 ,  C07D207/404 ,  C07D207/408 ,  C07D207/416 ,  C07D211/72 ,  C07D211/84 ,  C07D223/06 ,  C07D233/28 ,  C07D233/30 ,  C07D233/32 ,  C07D233/36 ,  C07D233/40 ,  C07D233/42 ,  C07D233/66 ,  C07D239/06 ,  C07D239/10 ,  C07D239/20 ,  C07D239/22 ,  C07D241/06 ,  C07D241/08 ,  C07D241/18 ,  C07D243/04 ,  C07D253/06 ,  C07D263/16 ,  C07D263/20 ,  C07D263/22 ,  C07D263/34 ,  C07D265/04 ,  C07D267/04 ,  C07D277/12 ,  C07D277/32 ,  C07D277/34 ,  C07D279/06 ,  C07D281/02 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D409/14 ,  C07D413/12 ,  C07D417/12

Abstract: A compound comprising a substituent of the formula (II) is disclosed as an HIV protease inhibitor. Intermediates for making such compounds and processes for making such intermediates are also disclosed.

公开(公告)号：DE69012541T2

公开(公告)日：1995-03-23

申请号：DE69012541

申请日：1990-12-21

Applicant: ABBOTT LAB

Inventor： KOLACZKOWSKI LAWRENCE ,  LITTLEFIELD MARK

IPC: G01N33/52 ,  A61K49/00 ,  C07D227/00 ,  C07D493/10 ,  C07K14/435 ,  C07K14/76 ,  C07K14/765 ,  C09B11/08 ,  C09B11/28 ,  C09B29/12 ,  G01N33/53 ,  G01N33/533

Abstract: A substituted monoethylglycinexylidide or analogue is disclosed. The xylidide or analogue has the structure of Fig. 1 of the attached drawings where M is CH2NHCH2CH3, CH2CH2CH2CH3 or CH2OCH2CH3, one of Y and Y is H and the other is a protein or a fluorescein moiety chemically bonded to the glycinexylidide or analogue moiety. Also disclosed is a method for carrying out immunoassays for MEGX, which has the structure of Fig. 3 of the attached drawings. The method for carrying out immunoassays involves using the foregoing compounds as tracers and immunogens.

公开(公告)号：BRPI0816221A8

公开(公告)日：2015-09-22

申请号：BRPI0816221

申请日：2008-10-10

Applicant: ABBOTT LAB ,  ABBVIE INC

Inventor： KOLACZKOWSKI LAWRENCE

IPC: C07D487/04 ,  A61K31/4184 ,  A61P35/00

公开(公告)号：CA2719425C

公开(公告)日：2014-08-12

申请号：CA2719425

申请日：2000-06-15

Applicant: ABBOTT LAB

Inventor： ALLEN MICHAEL S ,  PREMCHANDRAN RAMIYA H ,  CHANG SOU-JEN ,  CONDON STEPHEN ,  DEMATTEI JOHN J ,  KING STEVEN A ,  KOLACZKOWSKI LAWRENCE ,  MANNA SUKUMAR ,  NICHOLS PAUL J ,  PATEL HEMANT H ,  PATEL SUBHASH R ,  PLATA DANIEL J ,  STONER ERIC J ,  TIEN JIEN-HEH J ,  WITTENBERGER STEVEN J

IPC: C07D215/14 ,  C07C33/03 ,  C07C43/303 ,  C07C47/22 ,  C07C57/04 ,  C07C68/06 ,  C07C69/54 ,  C07C69/96 ,  C07C271/08 ,  C07D215/12 ,  C07D215/18 ,  C07D401/12 ,  C07H17/08

Abstract: The invention relates to a process for preparing quinoline-substituted carbonate and carbamate compounds, which are important intermediates in the synthesis of 6-O-substituted macrolide antibiotics. The process employs metal-catalyzed coupling reactions to provide a carbonate or carbamate of formula (I) or (II) or substrate that can be reduced to obtain the same.

公开(公告)号：DK1192139T3

公开(公告)日：2012-07-23

申请号：DK00942823

申请日：2000-06-15

Applicant: ABBOTT LAB

Inventor： ALLEN MICHAEL S ,  CONDON STEPHEN ,  DEMATTEI JOHN J ,  KOLACZKOWSKI LAWRENCE ,  MANNA SUKUMAR ,  PATEL HEMANT H ,  PATEL SUBHASH R ,  PLATA DANIEL J ,  STONER ERIC J ,  TIEN JIEN-HEH J ,  NICHOLS PAUL J ,  PREMCHANDRAN RAMIYA H ,  CHANG SOU-JEN ,  KING STEVEN A ,  WITTENBERGER STEVEN J

IPC: C07D215/14 ,  C07C33/03 ,  C07C43/303 ,  C07C47/22 ,  C07C57/04 ,  C07C68/06 ,  C07C69/96 ,  C07C269/06 ,  C07C271/12 ,  C07D215/18 ,  C07D401/12 ,  C07H17/08

公开(公告)号：NZ583209A

公开(公告)日：2012-06-29

申请号：NZ58320908

申请日：2008-10-10

Applicant: ABBOTT LAB

Inventor： KOLACZKOWSKI LAWRENCE

IPC: C07D487/04 ,  A61K31/4184 ,  A61P35/00

Abstract: Disclosed is crystalline form 1 of 2-((R)-2-Methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide, the physical parameters and characteristics of which are defined in the claims. The crystalline form 1 is used to treat cancer and is used as a radiosensitizer. Processes of making crystalline form 1 of 2-((R)-2-Methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide are also disclosed.

公开(公告)号：BRPI0708258A2

公开(公告)日：2011-05-24

申请号：BRPI0708258

申请日：2007-02-16

Applicant: ABBOTT LAB

Inventor： COWART MARLON D ,  ZHAO CHEN ,  SUN MINGHUA ,  BLACK LAWRENCE A ,  ZHENG GUO ZHU ,  GREGG ROBERT J ,  ZHANG GEOFF G ,  SHEIKH AHMAD Y ,  LOU XIAOCHUN ,  HENRY RODGER F ,  BARNES DAVID M ,  KOLACZKOWSKI LAWRENCE ,  HAIGHT ANTHONY R ,  CHANG SOU-JEN ,  WITTENBERGER STEVEN J ,  FICKES MICHAEL G

IPC: C07D487/04 ,  A61K31/407

Abstract: Octahydro-pyrrolo[3,4-b]pyrrole derivatives are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Octahydro-pyrrolo[3,4-b]pyrrole compounds, methods for using such compounds, compositions for making them, and processes for preparing such compounds are disclosed herein.